Expert physicians and clinical researchers summarize and explain all the
recent advances in the biology and treatment of bone marrow-based
malignancy. On the biological side, the authors show the characteristics
of the malignant cell and describe the significant roles played by
oncogenic changes, chromosomal anomalies, Kaposi's sarcoma herpes virus,
and cytokines. New epidemiological findings and prognostic factors are
also analyzed. On the clinical side, the authors provide a comprehensive
review of conventional treatment regimens, as well as a discussion of
newer experimental approaches involving immunologic targeting,
inhibitors of drug resistance, and antitumor agents.